BPC-157 Price: Cost per mg and per Week
What BPC-157 costs per mg by vial size, from dated public listings. No vendor links, no coupons.
Price per mg
Why prices vary
- Research-use products are unregulated, so a low price can mean less active peptide than the label says.
- Bigger vials usually cost less per mg, but only if the whole vial is used before it expires.
- Prices change often, which is why every figure here carries the date it was checked.
No published prices
The price dataset has no published vial size for BPC-157: it holds 0 observation rows, and a size needs at least 3 distinct sellers to be published.
Calculated from raw observation rows 0; min distinct sellers 3; dataset checked 2026-10-02. Formula: published sizes = sizes with at least 3 distinct sellers whose price was still on the page at the re-fetch; rows counted in research/sourced/market/prices/observations.csv
Regulatory context for BPC-157 listings
Drugs@FDA lists no BPC-157 product.[4]
FDA's compounding-risk page says it has identified no, or only limited, safety-related information for the routes of administration proposed for compounding BPC-157.[7]
Common questions
How much does BPC-157 cost?
We publish price per mg only from dated, public listings. We have not collected enough listings for BPC-157 to publish a figure. We never link to sellers.
Where can I buy BPC-157?
We don't link to or recommend sellers. BPC-157 is not an approved drug, and research-use products are not checked by the FDA for identity, purity or dose.
bpc 157 peptide for sale?
Drugs@FDA lists no approved BPC-157 product, and this page names no sellers.[4]
where to get bpc157?
No BPC-157 price is published here, because the price dataset has 0 observation rows for it.
Calculated from raw observation rows 0; min distinct sellers 3. Formula: published sizes require at least 3 distinct sellers
More on BPC-157
Sources
- 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "BPC-157" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 5US compounding: BPC-157 was removed from FDA's 503A category 2 because the nominators withdrew; FDA announced a Pharmacy Compounding Advisory Committee consultation on 23 July 2026 on whether to add it to the 503A bulks list.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 6World Anti-Doping Code: Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 7Official web pageOfficial web page · web page
Found an error? Report a correction.